Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aldeyra Therapeutics, Inc. | 125,670 | reported | 06 Mar 2018 | tx 8+477,855 |
| Stoke Therapeutics, Inc. | 40,000 | reported | 27 Mar 2024 | tx 38+711,033−461,376 |
| JAVELIN PHARMACEUTICALS, INC | 0 | reported | 02 Jul 2010 | tx 16+304,400−489,100 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 Mar 2024 | GRANT_AWARD | Stoke Therapeutics, Inc. | 60,000 | 0.00 USD | deriv |
| 27 Mar 2024 | GRANT_AWARD | Stoke Therapeutics, Inc. | 40,000 | 0.00 USD | deriv |
| 15 Mar 2024 | EXERCISE | Stoke Therapeutics, Inc. | 13,100 | 0.00 USD | |
| 19 Mar 2024 | SALE | Stoke Therapeutics, Inc. | 4,116 | 6.10 USD | |
| 15 Mar 2024 | EXERCISE | Stoke Therapeutics, Inc. | 13,100 | 0.00 USD | deriv |
| 01 Dec 2023 | OTHER | Stoke Therapeutics, Inc. | 107,400 | — | deriv |
| 01 Dec 2023 | GRANT_AWARD | Stoke Therapeutics, Inc. | 60,773 | 0.00 USD | deriv |
| 01 Dec 2023 | OTHER | Stoke Therapeutics, Inc. | 60,000 | — | deriv |
| 01 Dec 2023 | OTHER | Stoke Therapeutics, Inc. | 65,600 | — | deriv |
| 15 Mar 2023 | GRANT_AWARD | Stoke Therapeutics, Inc. | 52,400 | 0.00 USD | deriv |
| 15 Mar 2023 | GRANT_AWARD | Stoke Therapeutics, Inc. | 78,600 | 0.00 USD | deriv |
| 07 Dec 2022 | GRANT_AWARD | Stoke Therapeutics, Inc. | 62,000 | 0.00 USD | deriv |
| 02 Jun 2022 | EXERCISE | Stoke Therapeutics, Inc. | 11,160 | 4.48 USD | |
| 02 Jun 2022 | EXERCISE | Stoke Therapeutics, Inc. | 11,160 | 0.00 USD | deriv |
| 15 Mar 2022 | GRANT_AWARD | Stoke Therapeutics, Inc. | 107,400 | 0.00 USD | deriv |
| 02 Mar 2021 | GRANT_AWARD | Stoke Therapeutics, Inc. | 65,600 | 0.00 USD | deriv |
| 22 Feb 2021 | SALE | Stoke Therapeutics, Inc. | 9,696 | 59.29 USD | |
| 23 Feb 2021 | EXERCISE | Stoke Therapeutics, Inc. | 5,000 | 4.48 USD | |
| 23 Feb 2021 | SALE | Stoke Therapeutics, Inc. | 5,000 | 58.60 USD | |
| 22 Feb 2021 | SALE | Stoke Therapeutics, Inc. | 15,202 | 58.67 USD | |
| 22 Feb 2021 | EXERCISE | Stoke Therapeutics, Inc. | 25,000 | 4.48 USD | |
| 22 Feb 2021 | SALE | Stoke Therapeutics, Inc. | 102 | 60.00 USD | |
| 23 Feb 2021 | EXERCISE | Stoke Therapeutics, Inc. | 5,000 | 0.00 USD | deriv |
| 22 Feb 2021 | EXERCISE | Stoke Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 04 Nov 2020 | SALE | Stoke Therapeutics, Inc. | 11,111 | 41.42 USD |